BMO Capital Markets. "As the industry evolves, our priority is providing exceptional service to our clients while delivering more integrated and innovative solutions to grow our market leading ...
Dyne Therapeutics (NASDAQ:DYN) traded higher in the premarket on Wednesday after BMO Capital Markets launched its coverage with an Outperform recommendation and a $50 per share target, citing the ...
(Bloomberg) -- Bank of Montreal and Bank of Nova Scotia kicked off Canadian bank earnings season with strong results from their capital-markets divisions amid an increase in trading activity.
Bank of Montreal’s consistently bullish chief investment strategist isn’t blinking as U.S. President Donald Trump’s tariff ...
GE Vernova (NYSE:GEV – Free Report) had its price objective lowered by BMO Capital Markets from $471.00 to $420.00 in a report released on Monday morning,Benzinga reports. The brokerage currently has ...
Evertz Technologies (TSE:ET – Free Report) had its price target reduced by BMO Capital Markets from C$15.00 to C$13.50 in a research report report published on Thursday,BayStreet.CA reports.
BMO Capital analyst Kelly Bania raised the firm ... Hot Stocks on TipRanks >> Read More on SFM: Sprouts Farmers Markets NewsMORE Related Stocks Indices Commodities Currencies Stocks ...
BMO Capital initiated coverage of Rocket Pharmaceuticals (RCKT) with an Outperform rating and $50 price target The gene therapy company has “two major differences from the typical gene therapy ...
CIBC, TD Bank, BMO, Scotiabank, RBC and National Bank – released their first-quarter financial results this week ...
Key themes to include the impact of global events on commodities and capital markets and the evolution of the sector. "For more than 100 years, BMO has been a global leader and trusted advisor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results